hrp0092p2-161 | GH and IGFs | ESPE2019

The Influence of Pituitary MRI Findings on Clinical Presentation and Growth in GH-Treated Children with Congenital Hypopituitarism

Adel Djermane , Asmahane Ladjouze , Yasmine Ouarezki , Kahina Mohamedi , Hassina Benlarbi , Samira Aggoune , Zahir Bouzrar , Hachemi Maouche

Introduction: MRI imaging is the technique of choice in the diagnosis of children with hypopituitarism. Marked differences in MRI pituitary gland morphology suggest different etiologies of GHD, different clinical and endocrine outcome and different prognoses.Objective: To investigate the auxological, clinical and hypothalamic pituitary-MRI features in children with non-acquired growth hormone deficiency (GHD); and determ...

hrp0098p2-299 | Late Breaking | ESPE2024

A novel mutation in type 1 familial glucocorticoid deficiency associated with a deletion of chromosome 9

Kherra Sakina , Bellouti Sihem , Mohamedi Kahina , Sifour Latifa , Sahli Hassiba , Bouferoua Fadila , Zeroual Zoulikha , Roucher Florence , Laurence Michel

Introduction: Familial glucocorticoid deficiency (FGD), also known as hereditary resistance to ACTH, is a rare autosomal recessive disease characterized by an isolated deficiency of glucocorticoids. We report the case of a child who presented with type 1 FGD due to mutation of the ACTH receptor, melanocortin-2 receptor (MC2R), associated with monosomy 9p.Case presentation: A 1-day-old female patient was born to consangui...

hrp0098p2-185 | Growth and Syndromes | ESPE2024

A clinical follow-up of 46 Algerian patients with Prader Willi-Syndrome and their endocrine profile

Kherra Sakina , Ouarezki Yasmine , Djermanr Adel , Bouferoua Fadila , Bensalah Meriem , Mohamedi Kahina , Bellouti Sihem , Sfour Latifa , Sahli Hassiba , Talbi Fatiha , Zeroual Zoulikha , Ldjouze Asmahane

Introduction: Prader-Willi syndrome (PWS) is a rare neurodevelopmental genetic disease caused by the loss of expression of paternally inherited, imprinted genes on chromosome 15q11.2 q13.1, comprising multiple cognitive, behavioral and endocrine abnormalities. The estimated birth prevalence of PWS is approximately 1/15,000 - 25,000 live birthsObjective: The aimof this study was to identify clinical features and endocrine...

hrp0098p2-352 | Late Breaking | ESPE2024

Predictive factors for growth hormone response in the first year of treatment among children with growth hormone deficiency in Algeria

Kherra Sakina , Djermane Adel , Ouarezki Yasmine , Bouferoua Fadila , Bellouti Sihem , Sifour Latifa , Sahli Hassiba , Boutaghane Noureddine , Bensalah Meriem , Mohamedi Kahina , Chikh Amina , Ait Abdelkadder Belaid , Ladjouze Asmahane , Coutant Regis , Zeroual Zoulikha

Introduction: Several predictive factors of response to rGH have already been described in the literature such as age and height at the beginning of treatment, rGH dose and parental height status. However, few data exist on the predictive value of pre-therapeutic data on the response to rGH.The main objective of the study: is to identify predictive factors of the rGH response in children with GHD, with a particular inter...

hrp0098p2-354 | Late Breaking | ESPE2024

The IGF1 generation test as a tool to predict growth response to growth hormone treatment in children with growth hormone deficiency

Kherra Sakina , Ouarezki Yasmine , Djermane Adel , Sahli Hassiba , Sifour Latifa , Bellouti Sihem , Mohamedi Kahina , Boutaghane Noureddine , Bouferoua Fadila , Bensalah Meriem , Ladjouze Asmahane , Ait abdelkadder Belaid , Coutant Régis , Zoulikha Zeroual

Introduction: Serum levels of insulin growth factor (IGF1) could be a good indicator of growth hormone (GH) sensitivity and potentially GH therapy responsiveness. Few studies analyzed IGF1 generation test as predictor factor of the growth response to GH treatment in children with growth hormone deficiency (GHD) but results were controversial.Objective: The aimof the study was to evaluate the IGF-I generation test (IGF-I ...